INTERNATIONAL JOURNAL OF CARDIOLOGY, cilt.224, ss.323-327, 2016 (SCI-Expanded)
Objective: Many studies have revealed a role of YKL-40 as a new inflammatory biomarker in angiogenesis, inflammation, atherosclerosis and cardiovascular events. Thus, the aim of this study was to investigate the association of serum YKL-40 level with coronary collateral development and SYNTAX score in patients with stable coronary artery disease.